iSERA Lifesciences Announces Board Meeting to Consider Preferential Issue of Equity Shares

iSERA Lifesciences Announces Board Meeting to Consider Preferential Issue of Equity Shares​

iSERA Lifesciences Limited, formerly known as Covid Technologies Limited, has scheduled a Board Meeting of its Directors for Monday, April 20, 2026. The primary agenda for the meeting is the consideration and approval of a preferential issue of the Company's equity shares on a private placement basis.

The meeting will address the preferential issue of equity shares alongside several other business matters. This update provides stakeholders with details regarding the corporate action planned by the management.

Stock Price Movement​

At the close of trade today on Wednesday, Covidh Technologies Ltd. finished up, settling at ₹65.88, marking a strong 2.00% gain for its shares. The stock remained completely flat throughout the session, with the intraday range locking entirely at ₹65.88.

Source:​

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.